PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 19 filers reported holding PHIO PHARMACEUTICALS CORP in Q4 2021. The put-call ratio across all filers is 3.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 50 | -94.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 870 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 870 | -41.9% | 0.00% | – |
| Q1 2022 | $1,000 | – | 1,497 | +300.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 374 | -50.4% | 0.00% | – |
| Q3 2021 | $2,000 | -77.8% | 754 | -80.8% | 0.00% | – |
| Q2 2021 | $9,000 | -35.7% | 3,930 | -25.4% | 0.00% | – |
| Q1 2021 | $14,000 | +1300.0% | 5,270 | +2535.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 200 | -99.1% | 0.00% | – |
| Q1 2020 | $38,000 | – | 21,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 35,929 | $77,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 21,278 | $46,000 | 0.01% |
| UBS Group AG | 566 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 33 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HSBC HOLDINGS PLC | 11,337 | $24,000 | 0.00% |
| BlackRock Inc. | 19 | $0 | 0.00% |
| Citadel Advisors | 12,178 | $26,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 581 | $1,000 | 0.00% |